Patents by Inventor Sunil Sudhakar Chaudhari

Sunil Sudhakar Chaudhari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nanoparticulate formulation comprising a TRPA1 antagonist
    Patent number: 10603277
    Abstract: The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin-1 receptor (“TRPA1”) antagonist. Particularly, the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer; a process for preparing such formulation; and its use in treating a respiratory disorder or pain in a subject.
    Type: Grant
    Filed: June 20, 2014
    Date of Patent: March 31, 2020
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Ulhas Rameshchandra Dhuppad, Sunil Sudhakar Chaudhari, Suresh Mahadev Rajurkar, Nilesh Jayantilal Jain
  • NANOPARTICULATE FORMULATION COMPRISING A TRPA1 ANTAGONIST
    Publication number: 20140377358
    Abstract: The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin-1 receptor (“TRPA1”) antagonist. Particularly, the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer; a process for preparing such formulation; and its use in treating a respiratory disorder or pain in a subject.
    Type: Application
    Filed: June 20, 2014
    Publication date: December 25, 2014
    Inventors: Ulhas Rameshchandra DHUPPAD, Sunil Sudhakar CHAUDHARI, Suresh Mahadev RAJURKAR, Nilesh Jayantilal JAIN
  • Stable fixed dose topical formulation
    Patent number: 8673356
    Abstract: The present invention relates to stable fixed dose topical formulations comprising an antiacne agent and an antibiotic, which exhibit storage stability at a temperature of about 40° C. and relative humidity of about 75% for a period of at least 3 months. Particularly, the present invention relates to stable fixed dose topical formulations comprising therapeutically effective amounts of (a) adapalene-containing microspheres and (b) clindamycin, a process for their preparation thereof and their use for the treatment of acne.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: March 18, 2014
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Ulhas Rameshchandra Dhuppad, Nitin Babulal Bhamre, Sunil Sudhakar Chaudhari, Girish Ramakrishna Trivedi, Akhilesh Dayanand Sharma, Prashant Dongre
  • PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION
    Publication number: 20130028977
    Abstract: The present invention relates to a pharmaceutical powder composition for inhalation comprising an active ingredient and a pharmaceutically acceptable carrier, process for preparing such composition, and its use for the treatment of respiratory disorder in a subject.
    Type: Application
    Filed: March 30, 2011
    Publication date: January 31, 2013
    Applicant: GLENMARK PHARMACEUTICALS LIMITED
    Inventors: Ulhas Dhuppad, Sunil Sudhakar Chaudhari
  • Stable Fixed Dose Topical Formulation
    Publication number: 20100068284
    Abstract: The present invention relates to stable fixed dose topical formulations comprising an antiacne agent and an antibiotic, which exhibit storage stability at a temperature of about 40° C. and relative humidity of about 75% for a period of at least 3 months. Particularly, the present invention relates to stable fixed dose topical formulations comprising therapeutically effective amounts of (a) adapalene-containing microspheres and (b) clindamycin, a process for their preparation thereof and their use for the treatment of acne.
    Type: Application
    Filed: March 16, 2009
    Publication date: March 18, 2010
    Applicant: GLENMARK GENERICS LTD
    Inventors: Ulhas Rameshchandra Dhuppad, Nitin Babulal Bhamre, Sunil Sudhakar Chaudhari, Girish Trivedi, Akhilesh Dayanand Sharma, Prashant Dongre
  • Multiparticulate compositions for once-a-day administration
    Publication number: 20030219482
    Abstract: A pharmaceutical composition suitable for a once-a-day dosing regimen includes a combination of a biguanide and a sulfonylurea in the form of a multiparticulate, polyphasic system for the treatment of non-insulin dependent diabetes mellitus (NIDDM) and for improving glycemic control.
    Type: Application
    Filed: March 20, 2003
    Publication date: November 27, 2003
    Inventors: Sunil Sudhakar Chaudhari, Dilip Gopalkrishna Saoji, Harshal Prabhakar Bhagwatwar, Manjusha Malhotra, Milind C. Shukla, Noel John De Souza